The production value of biotechnology research and experimental development in Finland experienced significant fluctuations from 2014 to 2023, with notable peaks and troughs. As of 2023, the value stood at 92.0 Million Euros. Year-on-year variations reached remarkable points, such as a 70.26% increase in 2020 and an 11.52% increase in 2023. The five-year CAGR leading up to 2023 averaged 13.06%, highlighting a strong but fluctuating growth trajectory over the period.
Looking forward, the projected data from 2024 to 2028 indicates robust growth with a forecasted five-year CAGR of 6.45%, leading to a 36.69% overall increase by 2028. Future trends to watch for include technological advancements in biotechnology, increased funding for R&D, potential regulatory changes, and the impact of global market dynamics on the Finnish biotech industry. Understanding these variables will be crucial for stakeholders aiming to navigate and capitalize on this evolving market.
